Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-05-30
1979-03-27
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546121, C07D48704, A01N 922, A61K 3144
Patent
active
041466420
ABSTRACT:
Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3- position and a heterocyclic moiety on the pyrido portion of the molecule are active anthelmintic agents. The heterocyclic moiety is connected to the imidazo [1,2-a] pyridine molecule through an oxygen, sulfur, sulfinyl or sulfone. The novel compounds are prepared from the appropriately substituted 2-amino pyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.
REFERENCES:
patent: 3701780 (1972-10-01), Fisher
patent: 4028370 (1977-06-01), Irikura
Fisher et al., Journal Medicinal Chemistry, vol. 15, (No. 9), pp. 982-985 (1972).
Bochis Richard J.
Tolman Richard L.
Behan J. Jerome
Merck & Co. , Inc.
Rose David L.
Rotman Alan L.
LandOfFree
Heterocyclic substituted imidazo [1,2-a] pyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted imidazo [1,2-a] pyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted imidazo [1,2-a] pyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1822241